CRESCENT BIOPHARMA, INC. — Director's Dealing 2016

Jan 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLYCOMIMETICS INC (GLYC)
CIK: 0001253689
Period of Report: 2016-01-07

Reporting Person: Magnani John L. (Director, VP of Research, CSO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-07	Employee Stock Option (right to buy)	$5.22	A	71000	Acquired	2026-01-06	Common Stock (71000)	Direct

Footnotes

F1: One-fourth of the shares underlying this option vest on January 7, 2017 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.